n Cardiovascular Journal of South Africa - Cardio news
|Article Title||Cardio news|
|© Publisher:||Clinics Cardive Publishing|
|Journal||Cardiovascular Journal of South Africa|
|Publication Date||Sep 2003|
Extracted from text ... 288 Unsurpassed glycaemic control made simple The Pharmaceutical Division of Merck (Pty) Ltd, marketers of the most prescribed oral anti-diabetic agent, Glucophage, proudly announces the launch of the first fixed-combination drug therapy for unsurpassed glycaemic control - Glucovance(r). Glucovance(r) is a new treatment for improving blood glucose control for patients with type 2 diabetes who are inadequately controlled by existing oral treatments. Glucovance(r) offers unsurpassed glycaemic control in a single tablet. Glucovance(r), the first fixed-combination drug therapy for glycaemic control, brings together two tried and tested ingredients, metformin and glibenclamide, in one tablet. Both of these have been the mainstay of ..
Article metrics loading...